The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes.
Adaptor Proteins, Signal Transducing
/ genetics
Animals
Biomarkers, Tumor
/ genetics
Carbamoyl-Phosphate Synthase (Ammonia)
/ genetics
Carcinoma, Ovarian Epithelial
/ drug therapy
Cell Line, Tumor
Cell Survival
/ drug effects
Down-Regulation
/ drug effects
Drug Resistance, Neoplasm
/ genetics
Female
Humans
LIM Domain Proteins
/ genetics
Mice
Mice, Nude
Middle Aged
Multidrug Resistance-Associated Proteins
/ genetics
Ovarian Neoplasms
/ drug therapy
Paclitaxel
/ therapeutic use
Taxoids
/ therapeutic use
Transcription Factors
/ genetics
ABCC3
CPS1
Stony Brook taxanes
TRIP6
multidrug resistance
ovarian carcinoma
taxanes
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
22 Dec 2021
22 Dec 2021
Historique:
received:
22
10
2021
revised:
18
12
2021
accepted:
19
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
3
2
2022
Statut:
epublish
Résumé
The main problem precluding successful therapy with conventional taxanes is de novo or acquired resistance to taxanes. Therefore, novel experimental taxane derivatives (Stony Brook taxanes; SB-Ts) are synthesized and tested as potential drugs against resistant solid tumors. Recently, we reported alterations in
Identifiants
pubmed: 35008510
pii: ijms23010073
doi: 10.3390/ijms23010073
pmc: PMC8744980
pii:
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Biomarkers, Tumor
0
LIM Domain Proteins
0
Multidrug Resistance-Associated Proteins
0
TRIP6 protein, human
0
Taxoids
0
Transcription Factors
0
multidrug resistance-associated protein 3
1YV0492L5Z
CPS1 protein, human
EC 6.3.4.16
Carbamoyl-Phosphate Synthase (Ammonia)
EC 6.3.4.16
Paclitaxel
P88XT4IS4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Czech Science Foundation
ID : 19-03063S
Organisme : Czech Health Research Council
ID : NU20-09-00174
Organisme : Charles University
ID : PROGRES Q28
Organisme : Czech Ministry of Education, Youth and Sports
ID : INTER-COST, LTC19020
Organisme : NIH HHS
ID : R01 CA103314
Pays : United States
Références
Nature. 2017 Jun 1;546(7656):168-172
pubmed: 28538732
Biol Cell. 2011 Dec 1;103(12):573-91
pubmed: 22054418
Semin Oncol Nurs. 2019 Apr;35(2):151-156
pubmed: 30867104
Gynecol Oncol. 2010 May;117(2):198-201
pubmed: 19922990
Anticancer Res. 2005 Nov-Dec;25(6B):4215-24
pubmed: 16309219
J Exp Clin Cancer Res. 2012 Feb 13;31:14
pubmed: 22330607
J Cancer. 2017 Oct 9;8(17):3598-3606
pubmed: 29151946
PLoS One. 2016 May 12;11(5):e0155013
pubmed: 27171227
Cancer Med. 2019 Feb;8(2):606-616
pubmed: 30672151
J Biol Chem. 2009 May 22;284(21):14558-71
pubmed: 19293149
Int J Mol Sci. 2019 Jun 19;20(12):
pubmed: 31248089
Oncol Rep. 2016 Apr;35(4):2159-70
pubmed: 26820484
Expert Opin Drug Metab Toxicol. 2015 Feb;11(2):273-93
pubmed: 25380746
J Biol Chem. 2004 Mar 12;279(11):10459-68
pubmed: 14688263
J Biol Chem. 2007 Dec 28;282(52):37759-69
pubmed: 17965021
Curr Opin Plant Biol. 2004 Jun;7(3):254-61
pubmed: 15134745
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Nucleic Acids Res. 2002 May 1;30(9):e36
pubmed: 11972351
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):
pubmed: 24003207
Invest New Drugs. 2011 Jun;29(3):411-23
pubmed: 20013348
Toxicol Appl Pharmacol. 2016 Nov 1;310:215-228
pubmed: 27664577
Cancer Res. 2008 Jul 1;68(13):5380-9
pubmed: 18593940
Int J Mol Sci. 2016 Dec 15;17(12):
pubmed: 27983698
Turk J Gastroenterol. 2019 Apr;30(4):326-330
pubmed: 30945643
Naunyn Schmiedebergs Arch Pharmacol. 2012 Oct;385(10):1035-48
pubmed: 22855252
Int J Oncol. 2014 Aug;45(2):822-30
pubmed: 24898082
Am J Cancer Res. 2021 Sep 15;11(9):4127-4140
pubmed: 34659880
Nat Rev Cancer. 2015 Nov;15(11):668-79
pubmed: 26493647
Cancer Chemother Pharmacol. 2013 Jan;71(1):153-63
pubmed: 23053273
Cancers (Basel). 2020 Jun 17;12(6):
pubmed: 32560564
Drug Resist Updat. 2021 Mar;55:100754
pubmed: 33691261
Tumour Biol. 2015 Jun;36(6):4327-38
pubmed: 25596703
Mol Cancer Res. 2019 Jun;17(6):1351-1364
pubmed: 30808730
Adv Protein Chem Struct Biol. 2017;108:163-198
pubmed: 28427560
J Exp Clin Cancer Res. 2019 Aug 5;38(1):312
pubmed: 31378204
Lancet. 2021 Jan 23;397(10271):281-292
pubmed: 33485453
Cancers (Basel). 2021 Feb 11;13(4):
pubmed: 33670206
Mutagenesis. 2019 Dec 19;34(5-6):403-411
pubmed: 31375828
Toxicol Appl Pharmacol. 2018 May 15;347:79-91
pubmed: 29625142
N Engl J Med. 2019 Dec 19;381(25):2416-2428
pubmed: 31851799
Adv Biol Regul. 2019 Aug;73:100634
pubmed: 31053501
CA Cancer J Clin. 2019 Jul;69(4):280-304
pubmed: 31099893
Sci Rep. 2021 Apr 1;11(1):7400
pubmed: 33795761
Exp Cell Res. 2015 Apr 10;333(1):1-10
pubmed: 25557873
Mitochondrion. 2017 Mar;33:2-14
pubmed: 27444749
Oncology (Williston Park). 2018 Aug 15;32(8):418-20, 422-4
pubmed: 30153322
Gynecol Oncol. 2017 Feb;144(2):396-404
pubmed: 27919574
J Cell Physiol. 2018 Jun;233(6):5034-5043
pubmed: 29219179
J Cell Sci. 2012 Feb 15;125(Pt 4):807-15
pubmed: 22448037
Int J Mol Sci. 2019 Feb 22;20(4):
pubmed: 30813239
Cancers (Basel). 2021 Apr 06;13(7):
pubmed: 33917483
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Clin Oncol. 1991 Mar;9(3):389-93
pubmed: 1999708
Stem Cells. 2005 Oct;23(9):1417-22
pubmed: 16051985
Sci Rep. 2013 Nov 01;3:3120
pubmed: 24176985
J Natl Cancer Inst. 2017 Mar 1;109(3):1-9
pubmed: 28376202
Cancer Chemother Pharmacol. 2018 Jan;81(1):17-38
pubmed: 29249039
Zhonghua Yi Xue Za Zhi. 2014 Jul 15;94(27):2148-51
pubmed: 25327865
J Mol Cell Biol. 2016 Jun;8(3):282-5
pubmed: 27025967
Tumour Biol. 2016 Jan;37(1):1369-78
pubmed: 26298725
Naunyn Schmiedebergs Arch Pharmacol. 2005 Jul;372(1):95-105
pubmed: 16059735
J Nat Prod. 2009 Mar 27;72(3):554-65
pubmed: 19239240
Sci Rep. 2015 Nov 23;5:16950
pubmed: 26592762
Anticancer Res. 2009 Aug;29(8):2951-60
pubmed: 19661300
PLoS One. 2019 Feb 28;14(2):e0212097
pubmed: 30817750
Int J Oncol. 2017 Mar;50(3):893-902
pubmed: 28197640
Cancer Res. 2019 Jul 1;79(13):3332-3346
pubmed: 31018940
Tumour Biol. 2014 Nov;35(11):11097-105
pubmed: 25099619
Bioorg Chem. 2020 Jan;95:103523
pubmed: 31911305